The KYPHON Xpander™ II Inflatable Bone Tamp is intended to be used as a conventional bone tamp for the reduction of fractures and/or creation of a void in cancellous bone in the spine (including use during balloon kyphoplasty with a legally marketed PMMA-based bone cement that is cleared for use in kyphoplasty procedures) hand, tibia, radius and calcaneus.
Device Story
Inflatable bone tamp used for fracture reduction and void creation in cancellous bone; spine, hand, tibia, radius, calcaneus. Device consists of shaft, Y-adapter, and distal inflatable balloon. Operated by physician during surgical procedures. Balloon inflation creates void or reduces fracture; allows subsequent delivery of bone cement in kyphoplasty. Single-use, sterile device.
Clinical Evidence
Bench testing only. No clinical data presented. Testing included functional performance (balloon compliance, deflation time, insertion/withdrawal force, fatigue) and mechanical strength (tensile, torsional). Biocompatibility confirmed per ISO-10993.
Indicated for patients requiring fracture reduction or void creation in cancellous bone of the spine, hand, tibia, radius, or calcaneus. Includes use during balloon kyphoplasty with cleared PMMA-based bone cement.
Regulatory Classification
Identification
An arthroscope is an electrically powered endoscope intended to make visible the interior of a joint. The arthroscope and accessories also is intended to perform surgery within a joint.
{0}------------------------------------------------
K101864
OCT 1 4 2010
## Pre-Market Notification [510(k)] SUMMARY
| Summary Date: | September 29, 2010 |
|-------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Trade Name: | KYPHON Xpander <sup>TM</sup> II Inflatable Bone Tamp |
| Common Name: | Inflatable Bone Tamp |
| Classification Names: | Arthroscope (21CFR888.1100) |
| | Orthopedic Manual Surgical Instrument (21CFR 888.4540) |
| Device Codes: | HRX, HXG |
| Regulatory Class: | Class II |
| Manufacturer's Name: | Medtronic Spine LLC |
| Manufacturer's Address: | 1221 Crossman Avenue<br>Sunnyvale, CA 94089<br>Establishment Registration No. 2953769 |
| Contact Person: | Heinz J. Steneberg<br>Senior Regulatory Affairs Program Manager<br>Telephone: 408-548-6500<br>Fax: 408-548-6501 |
| Performance Standards: | The requirements of the Food Drug and Cosmetic Act, under<br>section 514 for performance standards, are not applicable to the<br>KYPHON Xpander <sup>TM</sup> II Inflatable Bone Tamps. |
| Predicate Devices: | KyphX® Xpander Inflatable Bone Tamp (K041454) |
| Intended Use: | The KYPHON Xpander <sup>TM</sup> II Inflatable Bone Tamp is intended<br>to be used as a conventional bone tamp for the reduction of<br>fractures and/or creation of a void in cancellous bone in the<br>spine (including use during balloon kyphoplasty with a legally<br>marketed PMMA-based bone cement that is cleared for use in<br>kyphoplasty procedures) hand, tibia, radius and calcaneus. |
:
.
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
{1}------------------------------------------------
| Device Description: | The KYPHON Xpander™ II Inflatable Bone Tamps are designed for reduction of fractures. The main components are the shaft, Y-Adapter and the inflatable balloon located at the distal tip. |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
The KYPHON Xpander™ II Inflatable Bone Tamps met the Testing: specifications and performance characteristics and are substantially equivalent to the predicate devices. The testing included functional testing, such as balloon compliance, deflation time, insertion/withdrawal force and fatigue testing as well as mechanical testing, such as tensile strength and torsional strength testing.
Biocompatibility testing of the KYPHON Xpander™ Biocompatibility: II Inflatable Bone Tamps confirmed that the devices meet applicable requirements of the FDA Blue Book Memorandum #G95-1 entitled "Use of International Standard ISO-10993, "Biological Evaluation of Medical Devices Part-1: Evaluation and Testing" and are biocompatible.
The KYPHON Xpander™ II Inflatable Bone Tamps will be Sterilization: provided sterile, for single-use only.
Packaging and Labeling: The KYPHON Xpander" II Inflatable Bone Tamps are packaged in a pouch made from polyamide, ultra-low density polyethylene and 1073B Tyvek® and a carton.
Substantial Equivalence: The information submitted in this premarket notification supports a determination that the KYPHON Xpander II Tamp is substantially equivalent Bone in Inflatable technological characteristics and intended use to the predicate devices. The products have the same fundamental scientific technology, basic design, functional characteristics and the same clinical application.
Submitted by:
Heinz J. Steneberg
MZ
Date Submitted:
September 29, 2010
{2}------------------------------------------------
## DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. In the center of the seal is an image of an eagle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Medtronic Spine LLC % Mr. Heinz J. Steneberg Senior Regulatory Affairs Program Manager 1221 Crossman Avenue Sunnyvale, California 94089
OCT 1 4 2010
Re: K101864
Trade/Device Name: KYPHON Xpander™ II Inflatable Bone Tamp Regulation Number: 21 CFR 888.1100 Regulation Name: Arthroscope Regulatory Class: Class II Product Code: HRX, HXG Dated: September 08, 2010 Received: September 09, 2010
## Dear Mr. Steneberg:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must
{3}------------------------------------------------
Page 2 - Mr. Heinz J. Steneberg
comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
- If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
ely yours,
Far
Mark N. Melkerson Director Division of Surgical, Orthopedic And Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
K101864
OCT. 14 2010
## INDICATIONS FOR USE
510(k) Number (if known):
Device Name: KYPHON Xpander™ II Inflatable Bone Tamp
Indications for Use:
The KYPHON Xpander™ II Inflatable Bone Tamp is intended to be used as a conventional bone tamp for the reduction of fractures and/or creation of a void in cancellous bone in the spine (including use during balloon kyphoplasty with a PMMA-based bone cement that is cleared for use in kyphoplasty procedures) hand, tibia, radius and calcaneus.
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use AND/OR (Over-The-Counter Use_
(PLEASE DO NOT WRITE BELOW THIS LINE)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Signature Sign-Off
n Sign-O (Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number -
K101864
Page ___ of_
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.